Anidulafungina w leczeniu kandydoz

Kalinowska, Katarzyna; Kudła, Anna; Baran, Eugeniusz
December 2010
Medical Mycology / Mikologia;2010, Vol. 17 Issue 4, p236
Academic Journal
In the last 15 years increasing amount of invasive fungal infections and occurrence of strains resistance to antifungals, has been very important clinical and epidemiological problem. The most common etiological agents are Candida species (60-80% of all infections) and Aspergillus species. With regard to increasing drug-resistance of microorganisms, introduction to treatment with echinocandins, including anidulafungin - semisynthetic lipopeptide, synthesized from fermentation products of Aspergillus nidulans, was very important braketrough.


Related Articles

  • Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. Drgona, L.; Khachatryan, A.; Stephens, J.; Charbonneau, C.; Kantecki, M.; Haider, S.; Barnes, R. // European Journal of Clinical Microbiology & Infectious Diseases;Jan2014, Vol. 33 Issue 1, p7 

    Invasive fungal diseases (IFDs) have been widely studied in recent years, largely because of the increasing population at risk. Aspergillus and Candida species remain the most common causes of IFDs, but other fungi are emerging. The early and accurate diagnosis of IFD is critical to outcome and...

  • Antifungal Susceptibility Profile of Cryptic Species of Aspergillus. Alastruey-Izquierdo, Ana; Alcazar-Fuoli, Laura; Cuenca-Estrella, Manuel // Mycopathologia;Dec2014, Vol. 178 Issue 5/6, p427 

    The use of molecular tools has led to the description of new cryptic species among different Aspergillus species complexes. Their frequency in the clinical setting has been reported to be between 10 and 15 %. The susceptibility to azoles and amphotericin B of many of these species is low, and...

  • Antifungal activity of some plant extracts against Clinical Pathogens. Mathur, Abhishek; Singh, Ravinder; Yousuf, Sajad; Bhardwaj, Aprajita; Verma, Satish K.; Babu, Pradeep; Gupta, Vinay; Prasad, G. B. K. S.; Dua, V. K. // Advances in Applied Science Research;Apr2011, Vol. 2 Issue 2, p260 

    The antifungal activity and minimum inhibitory concentration (MIC) of various plant extracts in different solvents such as hydro-alcohol (50 % v/v) and hexane of plants traditionally used as medicines as Valeriana jatamansi (Sugandhbala), Coleus barbatus (Pathar choor), Berberis aristata...

  • Clinical Pharmacokinetics: The First 30 Years. Speight, Trevor M.; Sjöqvist, Folke // Clinical Pharmacokinetics;2006, Vol. 45 Issue 7, p645 

    Voriconazole is the first available second-generation triazole with potent activity against a broad spectrum of clinically significant fungal pathogens, including Aspergillus,Candida, Cryptococcus neoformans, and some less common moulds. Voriconazole is rapidly absorbed within 2 hours after...

  • Speciation of Candida by Hicrome agar and Sugar assimilation test in both HIV infected and non infected patients. Manjunath, Veena; G. S., Vidya; Sharma, Archana; Prakash, Mridula Raj; Murugesh // International Journal of Biological & Medical Research;May2012, Vol. 3 Issue 3, p1778 

    Background: Candida spp. are the fourth most common pathogens isolated from blood cultures and the numbers of non-albicans Candida(NAC) with decreased susceptibility to anti-fungal agents are also increasing. Rapid identification of yeast isolates to the spp. level is essential in order to...

  • A β-1,3-glucanase gene expressed in fruit of Pyrus pyrifolia enhances resistance to several pathogenic fungi in transgenic tobacco. Liu, Diqiu; He, Xin; Li, Wenxian; Chen, Chaoyin; Ge, Feng // European Journal of Plant Pathology;Feb2013, Vol. 135 Issue 2, p265 

    β-1,3-glucanases, one of the well known families of pathogenesis-related (PR) proteins in responding to pathogen infection or some environmental stresses, are hydrolytic enzymes abundant in plants. The plant β-1,3-glucanases are considered to have a broad range of biological functions in...

  • Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system? de Pauw, Ben E.; Viscoli, Claudio // Journal of Antimicrobial Chemotherapy (JAC);Jan2011 Supplement 1, Vol. 66 Issue suppl_1, pi55 

    The management of invasive fungal disease in the immunocompromised host is complex and requires the specialized knowledge of physicians whose primary interest is actually the underlying disease rather than infectious complications. This Supplement aims to provide these physicians with some tools...

  • Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Nemati, Shadman; Hassanzadeh, Rasool; Khajeh Jahromi, Sina; Delkhosh Nasrollah Abadi, Azimeh // European Archives of Oto-Rhino-Laryngology;May2014, Vol. 271 Issue 5, p953 

    Otomycosis as a kind of external otitis can be caused by various species of fungi. To use the appropriate treatment, it is necessary to identify the causal agent of otomycosis. The aim of this study was to determine the pathogens that caused otomycosis and also the efficacy of different...

  • Fungal genetics: Good things come to those who wait. Skipper, Magdalena // Nature Reviews Microbiology;Feb2009, Vol. 7 Issue 2, p93 

    The article discusses the conditions under which human fungal pathogen Aspergillus fumigatus can reproduce sexually. There is the possibility of developing genetic tools for the organism and has important implications for understanding the evolution of pathogenicity and fungicide resistance. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics